Factors such as adoption of the nanofiltration technology, growth in the biopharmaceutical industry, and rapid development in generics production are driving the growth of this market. On the other hand, stern regulatory requirements and high price constraints are restraining the growth of this market.
The global Pharmaceutical Membrane Filtration Market is expected to reach USD 6.20 Billion by 2021 from USD 3.55 Billion in 2016, at a CAGR of 11.8% from 2016 to 2021. Factors such as growth in the biopharmaceutical industry and rapid growth in generic drug production are driving the growth of this market.
Download Free PDF Brochure: – http://www.marketsandmarkets.com/pdfdownload.asp?id=255408031
In this report, the global pharmaceutical membrane filtration market has been segmented based on product, technique, application, and region.
On the basis of product, the market has been segmented into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and other membrane filters.
Based on technique, the pharmaceutical membrane filtration market has been segmented into microfiltration, ultrafiltration, crossfiltration, nanofiltration, reverse osmosis, and ion exchange. The microfiltration segment is projected to witness the highest CAGR during the forecast period.
Based on application, the global pharmaceutical membrane filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. The final product processing segment is further divided into active pharmaceutical ingredient (API) filtration, sterile filtration, protein purification, vaccines & antibody processing, formulation & filling solutions, and viral clearance.
Based on region, the global pharmaceutical membrane filtration market is segmented into North America, Asia, Europe, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Growth in this regional segment is driven by factors such as increase in generic drug production and increasing incidence of airborne diseases.
Top Key Players:-
Key players in the pharmaceutical membrane filtration market include Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany), and Novasep (U.S.).